Biotech firm Debut completes Series B round at $40mBOLD, the venture capital fund of L'Oréal, led the round.ByIris Dorbian19 October 2023•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.Deals & ExitsBriefs